{"nctId":"NCT00704496","briefTitle":"The Effect of Pseudoephedrine on Rhinitis and Sleep","startDateStruct":{"date":"2007-06"},"conditions":["Rhinitis","Sleep"],"count":34,"armGroups":[{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Pseudoephedrine"]},{"label":"Pseudoephedrine","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Pseudoephedrine"]}],"interventions":[{"name":"Pseudoephedrine","otherNames":["Placebo"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Age 18 to 65.\n2. History of allergic rhinitis.\n3. The ability to be placed on placebo without significant compromise in the quality of life.\n4. General good health.\n5. Ability to comply with the protocol and sign an informed consent.\n6. Have daytime sleepiness by history.\n7. Have poor sleep by history.\n8. Have fatigue by history.\n9. Have a skin test or RAST test to a perennial allergen (indoor mold, dog, cat, mite) with correlating symptoms.\n\nExclusion Criteria:\n\n1. Age fewer than 18 or over 65 years.\n2. A history of sleep apnea.\n3. Atopic diseases other than allergic rhinitis, such as atopic dermatitis or asthma.\n4. Non-allergic rhinitis.\n5. Hypertension\n6. Diabetes Mellitus\n7. Inability to tolerate pseudoephedrine\n8. Significant other diseases as determined by the investigator.\n9. Use of a research medication within 30 days.\n10. Use of a nasal steroid or topical antihistamine or decongestant within 30 days.\n11. Use of beta-blockers, antidepressants, oral decongestants, oral steroids, or H2-blockers.\n12. Excessive use of alcohol or drug abuse.\n13. Inability to stop medication use during run-in period.\n14. Use of an oral antihistamine within 1 week of enrollment.\n15. Failed to have benefit when pseudoephedrine was used for rhinitis or asthma in the past","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Improvement of Sleep Associated With the Use of Pseudoephedrine as Compared to the Placebo","description":"sleep improvement by subjective questionnaires","classes":[]},{"type":"SECONDARY","title":"Improvement of Daytime Somnolence With Pseudoephedrine as Compared to Placebo","description":"daytime sleepiness by subjective questionnaires","classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}}